Quantcast
Genzyme could be off the block - Metro US

Genzyme could be off the block

CAMBRIDGE. Cambridge drug company Genzyme Corp. will likely be bought by a French company. Yesterday, Sanofi-Aventis SA put in a $18.5 billion public bid for Genzyme, a move that was rumored to be in the works for months. Genzyme shareholders would receive $69 per share.

More from our Sister Sites